Metraipolis › archive › dc_7e567b492f73

The Impact of Disease-Modifying Antirheumatic Drugs on In-Hospital Outcomes of Patients With COVID-19: A Retrospective Cohort Study and Literature Review — Europe PMC PMID:41773107

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41773107
DOI
10.7759/cureus.102637
License (as archived)
solo-consultazione
Archived
2026-11-06T09:53:30.176Z
SHA-256 of the archived text
c72a32579b6f807cd68609cc48034590345cdd7345d4ab94ca9227b8f0d89c14
Stable URL of this page
https://metraipolis.com/documento/dc_7e567b492f73

How to cite

The Impact of Disease-Modifying Antirheumatic Drugs on In-Hospital Outcomes of Patients With COVID-19: A Retrospective Cohort Study and Literature Review — Europe PMC PMID:41773107 — Europe PMC (en), https://europepmc.org/article/MED/41773107 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e567b492f73 (Metraipolis archive dc_7e567b492f73, sha256 c72a32579b6f807cd68609cc48034590345cdd7345d4ab94ca9227b8f0d89c14)
BibTeX
@misc{dc7e567b492f73,
  title = {The Impact of Disease-Modifying Antirheumatic Drugs on In-Hospital Outcomes of Patients With COVID-19: A Retrospective Cohort Study and Literature Review — Europe PMC PMID:41773107},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41773107},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e567b492f73; sha256 c72a32579b6f807cd68609cc48034590345cdd7345d4ab94ca9227b8f0d89c14},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41773107. Agents can read the archived copy with the MCP tool read_document.